— Know what they know.
Not Investment Advice
Also trades as: XBRA.CN (CNQ) · $vol 0M

XBRAF OTC

Xebra Brands Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -99.1% 1Y: -98.5% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $1525 mcap · 7M float · 0.0002% daily turnover · Short 46% of daily vol

Balance Sheet Trends

Total Assets
$379K -71.3% ▼
4Y CAGR: -47.9%
Total Liabilities
$790K +2.3% ▲
4Y CAGR: +6.6%
Shareholders Equity
-$155K -119.4% ▼
Cash & Investments
$102K -49.4% ▼
4Y CAGR: -42.8%
Total Debt
$0 +0.0% ▲
Net Debt
-$102K +49.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$955K$93K$647K$202K$102K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$955K$93K$647K$202K$102K
Net Receivables$44K$21K$137K$232K$107K
Inventory$0$0$0$155K$0
Other Current Assets$0$0$0$0$0
Total Current Assets$1M$334K$1M$696K$229K
Property, Plant & Equip.$467K$213K$330K$0$0
Goodwill & Intangibles$3M$3M$1M$470K$3
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$65K$79K$111K$158K$150K
Total Non-Current Assets$4M$3M$2M$628K$150K
Total Assets$5M$4M$3M$1M$379K
— Liabilities —
Accounts Payable$221K$512K$341K$623K$679K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$289K$552K$429K$772K$790K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$321K$67K$29K$0$0
Total Liabilities$611K$619K$457K$772K$790K
— Equity —
Common Stock$7M$8M$12M$14M$14M
Retained Earnings-$3M-$5M-$11M-$15M-$17M
Accumulated OCI$68K$36K$1M$2M$3M
Total Stockholders Equity$5M$3M$3M$796K-$155K
Total Liabilities & Equity$5M$4M$3M$1M$379K
— Key Metrics —
Total Debt$321K$67K$29K$0$0
Net Debt-$634K-$26K-$618K-$202K-$102K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms